SKI Market

Indian Indices

Nifty

25,019.80 -42.30
(-0.17%)

Sensex

82,330.59 -200.15
( -0.24%)

Bank Nifty

55,354.90 -0.70
( 0.00%)

Nifty IT

37,972.35 -321.45
( -0.84%)

Global Indices

Nasdaq

42,674.05 330.30
(0.78%)

Dow Jones

5,978.97 41.04
(0.69%)

Hang Seng

37,763.30 7.79
(0.02%)

Nikkei 225

8,684.56 50.81
(0.59%)

Forex

USD-INR

85.50 0.17
(0.19%)

EUR-INR

95.69 0.13
(0.13%)

GBP-INR

113.61 0.11
(0.10%)

JPY-INR

0.59 0.00
(0.74%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

513.6236355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

80.44

166750.11

EPS(TTM)

Face Value()

Div & Yield %

78.09

0.48

Back

Remus Pharmaceuticals Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

Apr 16,2025

Remus Pharmaceuticals Limited has informed the Exchange about submission of Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2025 under SEBI (Depositories and Participants) Regulations, 2018.

25,019.80 -42.30 (-0.17%)

82,330.59 -200.15 ( -0.24%)

55,354.90 -0.70 ( 0.00%)

37,972.35 -321.45 ( -0.84%)

42,674.05 330.30 (0.78%)

5,978.97 41.04 (0.69%)

37,763.30 7.79 (0.02%)

8,684.56 50.81 (0.59%)

85.50 0.17 (0.19%)

95.69 0.13 (0.13%)

113.61 0.11 (0.10%)

0.59 0.00 (0.74%)